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This research aims to compose nanofibers as a scaffold material in bone tissue engineering 
in terms of surface morphological properties and porosity. HA nanorod was prepared by 
the precipitation-ultrasonication method, while the PVA/CS/HA nanofiber composites 
were made by the electrospinning method using a static collector. HA was characterized 
by using XRD and SEM-EDX, while the PVA/CS/HA nanofiber composites used FTIR 
and SEM. The results show that HA nanorod has a crystalline size of 10.86 nm, 
crystallinity level of 52.38%, and Ca/P ratio of 1.70. From the SEM image shows HA 
nanorod width of 11.6 nm and 97.53 nm in length and some of it still in the form of HA 
nanoparticles. The diameter and porosity of PVA/CS/HA nanofiber with addition of 0%, 
10%, 20% HA were 275, 212, 265 nm and 72.94, 69.49, 70.81%, respectively. 
Keywords: Hydroxyapatite, PVA, chitosan, electrospinning. 
 
1. Introduction 
For more than a decade, the traditional methods of autograft and allograft bone grafts have been used 
to treat large-scale bone defects. These method is used of grafting the patient's own bone whereas 
allograft is a method of grafting a donor bone from another person/body [1]. However, these 
techniques has disadvantages of high surgical risks, such as bleeding, inflammation, infection, chronic 
disease, and high cost [2]. Whereas allograft bone grafts are associated with the risk of immunoreaction, 
infectious transmission, and have a record high failure rate for long term use [3], [4]. 
Scaffold engineering of bone tissue appears as a solution that can provide support for newly 
formed bone tissue, as a temporary site for interactive cell traffic and for the formation of the 
extracellular matrix of bone [5]. Hydroxyapatite (HA) meets the requirements as a scaffold biomaterial 
with mineral components similar to natural bone and has osteoconductivity, bone tissue binding ability, 
biocompatibility, affinity for biopolymers, and high osteogenic potential [6], [7]. HA crystals found in 
bone are generally nanometer-shaped needles (nanorods) with a dimension range of 60 nm long and 5–
20 nm wide [8]. 
Chitosan (CS) was chosen due to its various superior properties in medical and tissue engineering 
applications, including biodegradability, biocompatibility, non-toxic, hydrophilic, and anti-microbial 
properties [9], [10]. One of the modifications with synthetic polymer PVA is used to overcome the 
weakness of the properties of CS which is known to be difficult to form fibers. In addition, PVA also 
has several superior properties for application in the medical field, including biocompatibility, non-
toxicity, non-carcinogenicity, bioadhesive, and good mechanical properties [11]. 
In this study, HA nanorod synthesis was carried out using the precipitation-ultrasonication 
method, then it was composited with the PVA/CS polymer matrix, and the process of forming 
nanofibers using the electrospinning method. The effect of HA addition on surface morphological 
properties and porosity in PVA/CS/HA nanofiber composites was observed because in nanofiber 
scaffolds, these parameters have an important role in providing space for cell regeneration as a place to 
interact and form new tissue [12]. 
 





2.1. Synthesis of Hydroxyapatite 
The synthesis of HA nanorod was carried out by the precipitation-ultrasonication method. KH2PO4 
solution (0.19 M) was added dropwise to a solution of Ca(NO3)2 (0.32 M), stirred using a magnetic 
stirrer for 60 minutes at 80 °C, rotation speed of 600 rpm, and the reaction pH was maintained at pH 9 





























The solution obtained was sonicated for 30 minutes at 50 °C with ultrasonicator frequency of 45 kHz. 
Then the solution was precipitated using centrifugation at 2,200 rpm for 10 minutes. The precipitate 
was taken and washed with DI water, then dried at 110 °C for 5 hours. The sample is ready to XRD 
characterization process to determine the purity of the phase, crystal grain size, and crystallinity. SEM 
EDX to determine the structure and Ca/P ratio of the sample. 
2.2. Synthesis of PVA/CS/HA Nanofiber Composite 
Dissolve 0.52 grams of PVA powder in 4 ml of distilled water using a magnetic stirrer at a speed of 700 
rpm and a temperature of 110 °C for 3 hours. Dissolving 0.1 gram of chitosan in 5 ml of 2% acetic acid 
using a magnetic stirrer at a speed of 700 rpm and room temperature for 3 hours. The homogeneous 
dissolved PVA was added with chitosan and stirrer at a speed of 700 rpm and a temperature of 110 °C 
for 2 hours until it was homogeneous. Adding 10 and 20% HA powder to PVA/CS solution of 0.054 
and 0.108 grams respectively and stirrer at 700 rpm and 110 °C for 2 hours. The solution was sonicated 
for 30 minutes and then electrospinning with a needle to collector distance of 16.5 cm, an 
electrospinning voltage of 12 kV, and a flowrate of 80 ml/minute for 90 minutes. Make initial 
observations using an optical microscope to see the formation of nanofibers. The PVA/CS/HA 
composites were then characterization by FTIR and SEM. 
 
3. Result and Discussion 
3.1. Analysis XRD of Hydroxyapatite 
Figure 1 shows the XRD HA diffraction pattern of fitting results using Rietica software with a 
comparison database derived from Crystallography Open Database (COD) number 9013627 to 
determine the lattice parameters, crystal structure, and size of HA nanoparticles. Where the model has 
a lattice value a = b = 9.4081 Å and c = 6.8887 Å with a value of a = b ≠ c; α = β = 90°; γ = 120° which 
indicates that hydroxyapatite has a hexagonal crystal structure. The average value of the crystal size 
resulting from the refinement of the HA sample was 10.86 nm. Whereas in a study conducted by Mehta 
et al. [16] using the same method produced an average crystal size of 36.51 nm and found that giving 
temperature treatment by sintering could increase the crystal size of hydroxyapatite nanorod. 
 
 
Figure 1. Refinement hydroxyapatite XRD pattern. 




The degree of crystallinity from the XRD test results in this study is calculated using Equation 2. 
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From the calculation using this formula, the degree of crystallinity of the HA synthesized results is 
52.38%. This value fulfills the crystallinity level that must be met in the body, which is around 40–
60%. ISO standardized specifications (ISO 13779-1:2000) state that to make HA coatings that have 
sufficient mechanical strength, at least they must have a degree of crystallinity of more than 45%. This 
shows that the results of the synthesis of this hydroxyapatite sample have met the minimum crystallinity 
level of the given ISO standard. In previous studies proved that the degree of crystallinity of 
hydroxyapatite can be increased with increasing reaction temperature [13]–[16]. 
3.2. Analysis SEM-EDX of Hydroxyapatite 
Preparation of hydroxyapatite nanorod using the precipitation-ultrasonication method in this study 
produced hydroxyapatite in the form of partially agglomerated nanoparticles (see Figure 2). The length 
and width dimensions of the measurement results using ImageJ software obtained an average nanorod 
length of  97.53 nm and a width of 11.67 nm. 
The results of the elemental analysis from the SEM-EDX characterization in Figure 3 show that 
the Ca/P value in the hydroxyapatite sample in this study through the calculation of the elemental mass 
ratio is 1.70. This result is close to the mass ratio of Ca/P hydroxyapatite in natural bone which is 1.67 









Figure 3. SEM EDX hydroxyapatite results. 






Figure 4. FTIR spectrum of PVA/CS (grey line), PVA/CS/HA 10% (red line), and PVA/CS/HA 20% (blue line). 
 
3.3. Analysis FTIR of PVA/CS/HA Nanofiber Composite 
The FTIR test results in Figure 4, sample A1 (presented by grey line) shows the presence of PVA with 
the detection of the CH bending, CO stretching, and OH stretching functional groups at wave numbers 
around 1,435; 1,095; and 3,315 cm-1, respectively. The presence of chitosan with the appearance of the 
amide (NH) and amino (CH) functional groups at wave numbers 3,315 and 2,941 cm-1. From these 
results show the increasing HA concentration causes the hydroxyl (OH) functional group in sample A2 
(presented by red line) shift to the left (bigger) than sample A1 from 3,315 to 3,331 cm-1. This suggests 
that a stronger hydrogen bond is formed due to the increase in OH from the addition of hydroxyapatite 
[20]. In the A3 (presented by blue line) sample the hydroxyl group shifted back to a smaller wave 
number at 3,315 cm-1 which reflects the agglomeration of HA. The agglomeration that occurs will 
reduce the interaction between the surface of the HA nanoparticles and the polymer, so that the active 
OH groups on the surface of the two materials will have less opportunity to interact with each other 
[21]. 
3.4. Analysis SEM of PVA/CS/HA Nanofiber Composite 
Figure 5(a) shows that the surface morphology of the PVA/CS matrix produces fibers that are quite 
homogeneous, continuous, and without beads. This shows that the PVA/CS composite has dissolved 
well and the electrospinning parameters (needle to collector distance, voltage, and flowrate) are 
appropriate. Figure 5(b) shows the addition of 10% HA to produce a homogeneous, continuous fiber, 
and there are few beads due to the agglomerated HA. Whereas in Figure 5(c) the addition of 20% HA 
shows less homogeneous fibers, almost broken, and there are many beads with micron-sized 
agglomerations that can cause the scaffold to underperform in cell adhesion and proliferation [22]. 
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Figure 5. SEM characterization results at magnification of 10,000 times nanofiber (a) PVA/CS, (b) PVA/CS/HA 10%, and 
(c) PVA/CS/HA 20%. 
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Figure 6. Nanofiber diameter distribution of (a) PVA/CS, (b) PVA/CS/HA 10%, and (c) PVA/CS/HA 20%. 
 








PVA/CS 72.94 204 – 457 (274.94 ± 1.90) 
PVA/CS/HA 10% 69.49 118 – 340 (211.77 ± 3.60) 
PVA/CS/HA 20% 70.81 160 – 456 (264.99 ± 4.71) 
 
The fiber diameter distribution is shown in Figure 6 that the level of homogeneity of the fiber 
diameter size decreases with the addition of HA. The average diameter size of PVA/CS/HA fibers 
decreased in the nanofiber composites without HA to the addition of 10% HA. The smaller size of the 
fiber diameter is due to the increased viscosity of the solution with the addition of HA [23]. Meanwhile, 
the addition of 20% HA indicates that the fiber diameter increases again due to a lot of HA 
agglomeration which causes the HA interaction with the PVA/CS matrix to be disturbed so that when 
the fiber formation becomes unstable which results in the formation of beads and the fiber diameter size 
is not homogeneous. Natural bone tissue itself has organic matrix fibers that range in diameter from 100 
to 450 nm [24]. 
Table 1 shows the results of the porosity and fiber diameter which shows a unidirectional 
relationship. This happens because the simple porosity calculation using OriginPro software depends 
on the SEM test results' surface area and fiber thickness. The PVA/CS/HA 10% composite, which 
shows a smaller fiber diameter, causes a smaller surface area and a larger pile of fibers. Thicker than 
the addition of HA 0 and 20% resulted in less porosity. The greater the porosity the greater the size of 
the fiber diameter, and vice versa, the smaller the porosity, the smaller the fiber diameter size [23]. The 
tendency for fibers to accumulate will result in poor porosity and reduced pore size [25].  
 
4. Conclusion 
The synthesized hydroxyapatite has a hexagonal crystal structure, a crystal size of 10.86 nm and a 
crystallinity level of 52.38% with a Ca/P ratio close to the ideal value of HA (1.67), which is 1.70. HA 
nanorod has been successfully synthesized with dimensions of 97.53 nm in length and 11.67 nm in 
width with part of it in the form of HA nanoparticles. The addition of HA concentrations in the 
PVA/CS/HA nanofiber composites can reduce the size of the fiber diameter thereby increasing the 
surface area of the fiber. In the other hand the addition of highest HA concentration affected in reduced 
fiber homogeneity, nearly cut fibers, HA agglomeration, and the formation of beads. The porosity of 
the PVA/CS/HA nanofiber composites has a direct relationship with the average fiber diameter and is 
inversely related to the thickness of the nanofiber. 
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